Delivery Order SPE2DE24DA017-SPE2D625F2ZW8
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, classified as a non-set-aside delivery order with an ultimate completion date of August 22, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,650 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 8, 2025, represents a task order issued under Arthrex's significant Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471.0 million and spanning from June...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $9,900 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on September 3, 2025, with an ultimate completion date of September 17, 2025. The award represents a non-set-aside competitive procurement and will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order, valued at $3,300, is scheduled for completion by September 9, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F2ZW8Delivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $4,356.00 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by June 24, 2025, and represents a specific task order issued under Arthrex's larger indefinite delivery contract (SPE2DE24D0020) with the Defense Logistics Agency. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal medical device marketplace. The ACP Double Syringe System is a specialized orthopedic medical device designed to support surgical procedures across the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order exemplifies the ongoing utilization of Arthrex's comprehensive indefinite delivery contract, valued at approximately $471 million and running through September 1, 2029, which enables Veterans Integrated Service Networks and military medical facilities nationwide to procure advanced orthopedic technologies. The Medical Supply Chain, as the funding federal agency, continues to leverage this vehicle to efficiently access Arthrex's full portfolio of orthopedic solutions, including surgical implants, arthroscopic instruments, and specialized surgical systems tailored to meet the healthcare requirements of veterans and active-duty military personnel. To date, Arthrex has exceeded $550,000 in delivery orders under this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 6/18/25 |